Back

A prospective study of a novel pocket compression device to reduce pocket hematoma after cardiac implantable electronic device implantation in a high bleeding risk population

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: Pacemaker implantation and management: novel challenges and improvements Device Treatment ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Maxime Tijskens

AZ Rivierenland, Antwerp (Belgium)

5 More presentations in this session

Presentation thumbnail
Predictor of A4-amplitude using preprocedural electrocardiography in patients with leadless pacemakers
Doctor S. Kawatani (Yonago, JP)
Abstract Slides Video
Presentation thumbnail
Clinical evidence of pacemaker implantation during gestation: a case series
Professor A. Abdrakhmanov (Astana, KZ)
Abstract Slides Video
Presentation thumbnail
The effect of afterload on right ventricular pacing-induced left ventricular dysfunction: a translational study
Assistant Professor M. Ruppert (Boston, US)
Abstract Slides Video
Presentation thumbnail
Association between current of injury and intraoperative R wave amplitude fluctuation immediately after active fixation pacing lead implantation
Doctor Y. Oshima (Gifu, JP)
Abstract Slides Video
Presentation thumbnail
Long-term follow-up of single-chamber atrial pacing - system upgrade and wenckebach block point behavior: potential implications for leadless AAI pacing?
Ms R. Arnet (Basel, CH)
Abstract Slides Video

Access the full session

Session thumbnail
Pacemaker implantation and management: novel challenges and improvements

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024
You may be interested in
thumbnail
Congress Presentation
The efficacy of compression dressings to reduce haematoma post cardiac implantable electronic devices - a systematic review and meta-analysis.
thumbnail
Congress Presentation
Pocket-related complications after cardiac electronic devices implantation in patients on anticoagulation or dual antiplatelet therapy: comparison of Premofix and SafeGuard Focus compression device
thumbnail
Congress Presentation
Antithrombotic therapy and the risk of pocket hematoma after subcutaneous implantable cardioverter-defibrillator implantation

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources